Suppr超能文献

[睡眠呼吸暂停与心力衰竭]

[Sleep apnea and heart failure].

作者信息

Plenge T, Müller-Ehmsen J

机构信息

Klinik III für Innere Medizin, Herzzentrum Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.

出版信息

Herz. 2013 Sep;38(6):604-9. doi: 10.1007/s00059-013-3878-z.

Abstract

Sleep apnea can influence cardiac function, by which the development of heart failure is facilitated. Vice versa, chronic heart failure increases the risk for sleep apnea. Consequently, in patients with symptomatic chronic heart failure, sleep apnea is a frequent comorbidity occuring in up to 75% of cases. More than half of those suffer from central sleep apnea, whereas in the general population, obstructive sleep apnea is far more frequent. Both, the obstructive and the central sleep apnea lead to oxygen desaturations during the night which are followed by increases in serum catecholamines. Possibly, this is the main mechanism why the prognosis of patients with symptomatic heart failure and sleep apnea is much worse than that of patients without sleep apnea. Therefore, a screening of all heart failure patients for sleep apnea is mandatory. Currently, large studies are underway which investigate whether the treatment of sleep apnea, esp. central sleep apnea, will beneficially influence the clinical course of heart failure (SERVE-HF, ADVENT-HF). A new therapeutic approach for central sleep apnea is the phrenic nerve stimulation.

摘要

睡眠呼吸暂停可影响心脏功能,进而促进心力衰竭的发展。反之,慢性心力衰竭会增加睡眠呼吸暂停的风险。因此,在有症状的慢性心力衰竭患者中,睡眠呼吸暂停是一种常见的合并症,发生率高达75%。其中一半以上患有中枢性睡眠呼吸暂停,而在普通人群中,阻塞性睡眠呼吸暂停更为常见。阻塞性和中枢性睡眠呼吸暂停都会导致夜间血氧饱和度下降,随后血清儿茶酚胺升高。这可能是有症状心力衰竭和睡眠呼吸暂停患者的预后比无睡眠呼吸暂停患者差得多的主要机制。因此,对所有心力衰竭患者进行睡眠呼吸暂停筛查是必不可少的。目前,正在进行大型研究,以调查睡眠呼吸暂停的治疗,尤其是中枢性睡眠呼吸暂停的治疗,是否会对心力衰竭的临床病程产生有益影响(SERVE-HF、ADVENT-HF)。一种治疗中枢性睡眠呼吸暂停的新方法是膈神经刺激。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验